Yosemite Pathology Medical Group, Inc. – Trademark Portfolio
Entity Type: 03
Yosemite Pathology Medical Group, Inc. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 15 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include CYTQ, GYNQ, UROQ, HEMAQ, and DERMAQ. The owner is based in Modesto, CA.
4301 Northstar Way
Modesto, CA 953569262
Showing of trademarks Trademarks
Trademark Classifications
Yosemite Pathology Medical Group, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Yosemite Pathology Medical Group, Inc. have?
Yosemite Pathology Medical Group, Inc. has 15 U.S. trademarks filed with the USPTO. Of these, 12 registered, 2 abandoned, 1 cancelled.
What trademark classes does Yosemite Pathology Medical Group, Inc. file in?
Yosemite Pathology Medical Group, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Yosemite Pathology Medical Group, Inc.'s most well-known trademarks?
Yosemite Pathology Medical Group, Inc.'s registered trademark portfolio includes well-known marks such as CYTQ, GYNQ, UROQ, HEMAQ, and DERMAQ. These are among 12 currently registered trademarks in the portfolio.
What is Yosemite Pathology Medical Group, Inc.'s trademark registration success rate?
Yosemite Pathology Medical Group, Inc. has a 80% trademark registration rate, with 12 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.